ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACSBG1 | Acyl-CoA synthetase bubblegum family member 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSBG2 | Acyl-CoA synthetase bubblegum family member 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ACSL1 | Acyl-CoA synthetase long-chain family member 1 | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL3 | Acyl-CoA synthetase long-chain family member 3 | Cancer-related genes Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL4 | Acyl-CoA synthetase long-chain family member 4 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL5 | Acyl-CoA synthetase long-chain family member 5 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM3 | Acyl-CoA synthetase medium-chain family member 3 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSM4 | Acyl-CoA synthetase medium-chain family member 4 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enriched |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSM6 | Acyl-CoA synthetase medium-chain family member 6 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACSS1 | Acyl-CoA synthetase short-chain family member 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSS2 | Acyl-CoA synthetase short-chain family member 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSS3 | Acyl-CoA synthetase short-chain family member 3 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
ACVR1 | Activin A receptor, type I | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACVR1B | Activin A receptor, type IB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACVR2A | Activin A receptor, type IIA | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ACVR2B | Activin A receptor, type IIB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ACVRL1 | Activin A receptor type II-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
ACYP1 | Acylphosphatase 1, erythrocyte (common) type | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ACYP2 | Acylphosphatase 2, muscle type | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM15 | ADAM metallopeptidase domain 15 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM19 | ADAM metallopeptidase domain 19 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM29 | ADAM metallopeptidase domain 29 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM30 | ADAM metallopeptidase domain 30 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADAM32 | ADAM metallopeptidase domain 32 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM33 | ADAM metallopeptidase domain 33 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM9 | ADAM metallopeptidase domain 9 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |